Patents by Inventor Motohiro Kobayashi
Motohiro Kobayashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170336626Abstract: [Object] To provide display that is more favorable to a user. [Solution] Provided is a display device including: a pixel array; and a microlens array provided on a display surface side of the pixel array and having lenses arranged at a pitch larger than a pixel pitch of the pixel array. The microlens array is arranged so that each lens of the microlens array generates a virtual image of display of the pixel array on a side opposite to a display surface of the pixel array, and light emitted from each lens of the microlens array is controlled so that pictures visually recognized through lenses of the microlens array become a continuous and integral display by controlling the light from each pixel of the pixel array.Type: ApplicationFiled: November 6, 2015Publication date: November 23, 2017Applicant: Sony CorporationInventors: Masatake Hayashi, Takeo Arai, Motohiro Kobayashi
-
Patent number: 7087624Abstract: Substituted pyrazole compounds represented by formula (I), or salts thereof are disclosed, wherein R1 is —CH(OH)—CH(R4)-(A)n-Y, —CH2—CH(R4)-(A)n-Y, —CO-B1-A-Y or the like (wherein A is a lower alkylene; Y is an aryl group which may be substituted, for example, by halogen, or the like; R4 is a hydrogen atom or a lower alkyl group; B1 is —CH(R4)— or —N(R4)—; and n is 0 or 1); R2 is a hydrogen atom, a lower alkyl group which may be substituted by hydroxyl or the like, or an aralkyl group; R3 is a phenyl group which may be substituted by halogen or the like, or a pyridyl group; and Q is a pyridyl or quinolyl group.Type: GrantFiled: October 27, 2003Date of Patent: August 8, 2006Assignee: Teikoju Hormone Mfg. Co., Ltd.Inventors: Nobuyoshi Minami, Michitaka Sato, Koichi Hasumi, Norio Yamamoto, Katsuyuki Keino, Teruaki Matsui, Arihiro Kanada, Shuji Ohta, Takahisa Saito, Shuichiro Sato, Akira Asagarasu, Satoshi Doi, Motohiro Kobayashi, Jun Sato, Hajime Asano
-
Publication number: 20040087628Abstract: Substituted pyrazole compounds represented by formula (I), or salts thereof are disclosed, wherein R1 is —CH(OH)—CH(R4)-(A)n —Y, —CH2 —CH(R4)-(A)n—Y, —CO—B1-A-Y or the like (wherein A is a lower alkylene; Y is an aryl group which may be substituted, for example, by halogen, or the like; R4 is a hydrogen atom or a lower alkyl group; B1 is —CH(R4)— or —N(R4)—; and n is 0 or 1); R2 is a hydrogen atom, a lower alkyl group which may be substituted by hydroxyl or the like, or an aralkyl group; R3 is a phenyl group which may be substituted by halogen or the like, or a pyridyl group; and Q is a pyridyl or quinolyl group. These substituted pyrazole compounds or their salts have an excellent p38MAP kinase inhibiting effect and are hence useful in the prevention or treatment of tumor necrosis factor &agr;-related diseases, interleukin 1-related diseases, interleukin 6-related diseases or cyclooxygenase II-related diseases.Type: ApplicationFiled: October 27, 2003Publication date: May 6, 2004Inventors: Nobuyoshi Minami, Michitaka Sato, Koichi Hasumi, Norio Yamamoto, Katsuyuki Keino, Teruaki Matsui, Arihiro Kanada, Shuji Ohta, Takahisa Saito, Shuichiro Sato, Akira Asagarasu, Satoshi Doi, Motohiro Kobayashi, Jun Sato, Hajime Asano
-
Patent number: 6667325Abstract: Substituted pyrazole compounds represented by formula (I), or salts thereof are disclosed, wherein R1 is —CH(OH)—CH(R4)—(A)n—Y, —CH2—CH(R4)—(A)n—Y, —CO—B1—A—Y or the like (wherein A is a lower alkylene; Y is an aryl group which may be substituted, for example, by halogen, or the like; R4 is a hydrogen atom or a lower alkyl group; B1 is —CH(R4)— or —N(R4)—; and n is 0 or 1); R2 is a hydrogen atom, a lower alkyl group which may be substituted by hydroxyl or the like, or an aralkyl group; R3 is a phenyl group which may be substituted by halogen or the like, or a pyridyl group; and Q is a pyridyl or quinolyl group. These substituted pyrazole compounds or their salts have an excellent p38MAP kinase inhibiting effect and are hence useful in the prevention or treatment of tumor necrosis factor &agr;-related diseases, interleukin 1-related diseases, interleukin 6-related diseases or cyclooxygenase II-related diseases.Type: GrantFiled: December 3, 2001Date of Patent: December 23, 2003Assignee: Teikoku Hormone Mfg. Co., Ltd.Inventors: Nobuyoshi Minami, Michitaka Sato, Koichi Hasumi, Norio Yamamoto, Katsuyuki Keino, Teruaki Matsui, Arihiro Kanada, Shuji Ohta, Takahisa Saito, Shuichiro Sato, Akira Asagarasu, Satoshi Doi, Motohiro Kobayashi, Jun Sato, Hajime Asano
-
Patent number: 6511997Abstract: Aminopyrazole derivatives represented by formula (I), or salts thereof, wherein X1 and X2 are each a hydrogen atom or a halogen atom, or X1 and X2 may be united together to form a lower alkylenedioxy group, Q is a pyridyl group or a quinolyl group, R1 is a hydrogen atom, a substituted or unsubstituted lower alkyl or aryl group, R2 is a hydrogen atom, a lower alkyl group, or an aralkyl group, and R3 represents a hydrogen atom, an organic sulfonyl group, or —C(═Y)—R4 in which R4 is a hydrogen atom or an organic residue and Y is an oxygen or sulfur atom, provided that, when R3 is a hydrogen atom, R1 is a group other than a hydrogen atom and R2 is a hydrogen atom. These amimopyrazole derivatives or their salts have excellent p38MAP kinase inhibiting activities and are hence useful in the prevention or treatment of diseases associated with tumor necrosis sis factor &agr;, interleukin 1, interleukin 6 or cyclooxygenase II.Type: GrantFiled: June 22, 2001Date of Patent: January 28, 2003Assignee: Teikoku Hormone Mfg. Co., Ltd.Inventors: Nobuyoshi Minami, Michitaka Sato, Koichi Hasumi, Norio Yamamoto, Katsuyuki Keino, Teruaki Matsui, Arihiro Kanada, Shuji Ohta, Takahisa Saito, Shuichiro Sato, Akira Asagarasu, Satoshi Doi, Motohiro Kobayashi, Jun Sato, Hajime Asano
-
Patent number: 6142760Abstract: A drive control apparatus is provided for an electric injection molding machine, in which a screw is used to inject melted resin into a cavity of a metal mold. Herein, the screw is driven to move in a desired direction by using first and second servo motors, which are connected together using a belt, for example. In the drive control apparatus, a motion controller produces a drive control signal to control operation of the screw. A master servo amplifier inputs the drive control signal to control the first servo motor, wherein a position of a rotor of the first servo motor is detected and is used as a feedback value. The master servo amplifier further produces a torque instruction signal representing a ratio against rated output of the first servo motor by which the first servo motor is to be driven. For example, frequency of the torque instruction represents rotation speed of the motor, while amplitude represents magnitude of torque.Type: GrantFiled: December 24, 1998Date of Patent: November 7, 2000Assignee: Niigata Engineering Co., Ltd.Inventors: Nobuya Niizeki, Motohiro Kobayashi
-
Patent number: 6124431Abstract: A peptide derivative represented by the following formula or a salt thereof ##STR1## wherein A represents a hydrogen atom, and B represents a phenyl group substituted with a hydroxyl group;said derivative has an antitumor activity stronger than that of dolastatin 10, and is useful as an anticancer or antitumor agent.Type: GrantFiled: March 16, 1998Date of Patent: September 26, 2000Assignee: Teikoku Hormone Mfg. Co., Ltd.Inventors: Kyoichi Sakakibara, Masaaki Gondo, Koichi Miyazaki, Takeshi Ito, Akihiro Sugimura, Motohiro Kobayashi
-
Patent number: 6115513Abstract: An information input method and interface, which can easily be operated without direct awareness of hardware, are provided. Image recognition is performed with an image recognition unit on image information obtained from imaging a target pattern on an object surface and an access indication pattern created by a user. The input patterns are created with an image pickup unit. The target pattern is associated with corresponding information stored in a storage unit. An access indication input which specifies a subset of the information is generated by performing image recognition on the access indication pattern. A control operation corresponding to the access indication input is performed in response to the access indication input by a control unit.Type: GrantFiled: November 17, 1997Date of Patent: September 5, 2000Assignee: Sony CorporationInventors: Mitsuhiro Miyazaki, Hiroshi Usuda, Motohiro Kobayashi
-
Patent number: 5840699Abstract: This invention relates to peptide derivatives of the formula ##STR1## or salts thereof, wherein: (a) Q.sub.1 represents a 1-dimethylamino-2-methylpropyl group and Q.sub.2 represents an (R)- or (S)-2-hydroxy-2-phenylethylamino group, a 2-phenylcyclopropylamino group or a 1,2,3,4-tetrahydroisoquinolin-2-yl group, or(b) Q.sub.1 represents a 1-methyl-2-pyrrolidinyl group and Q.sub.Type: GrantFiled: October 21, 1997Date of Patent: November 24, 1998Assignee: Teikoku Hormone Mfg. Co. Ltd.Inventors: Kyoichi Sakakibara, Masaaki Gondo, Koichi Miyazaki, Takeshi Ito, Akihiro Sugimura, Motohiro Kobayashi
-
Patent number: 5767237Abstract: A peptide derivative represented by the following formula or a salt thereof ##STR1## wherein A and B each represent either of the following (a) and (b), (a) A represents a hydrogen atom, and B represents a phenyl group substituted with a halogen atom, hydroxyl group, lower alkyl group or lower alkoxy group, or a heteroaryl group,(b) A represents --CONH--R.sup.1, --CSNH--R.sup.1, a hydroxymethyl group, a lower alkoxycarbonyl group or a carboxyl group, wherein, R.sup.1 represents a lower alkyl group or a heteroaryl group, and B represents a phenyl group optionally substituted with a halogen atom, hydroxyl group, lower alkyl group or lower alkoxy group,has an antitumor activity stronger than that of dolastatin 10, and is useful as an anticancer or antitumor agent.Type: GrantFiled: April 1, 1996Date of Patent: June 16, 1998Assignee: Teikoku Hormone Mfg. Co., Ltd.Inventors: Kyoichi Sakakibara, Masaaki Gondo, Koichi Miyazaki, Takeshi Ito, Akihiro Sugimura, Motohiro Kobayashi
-
Patent number: 5492658Abstract: The present intention intends to operate an ejector which carries out gate cut and product ejection in an injection molding machine, at optimal speeds, respectively. According to the present invention, a control unit for controlling hydraulic or electric drive means for operating one or more than one ejector pin comprises operation speed setting means for gate cut and another operation speed setting means for product ejection. Such a structure enables to carry out gate cut by operating an ejector unit controlled by an ejector unit operation speed setting means for a gate cut and, subsequently, to carry out a product ejection from metallic molds by operating the ejector unit controlled by another ejector unit operation speed setting means for product ejection. The ejector unit is set at a comparatively high operation speed for gate cut so that no gate trace will remain, and at a comparatively low operation speed for product ejection so that no cracks will be generated in the product.Type: GrantFiled: December 19, 1994Date of Patent: February 20, 1996Assignee: Sankyokasei Kabushiki KaishaInventors: Masakazu Ohno, Yukio Yoshizawa, Shoji Miyajima, Sumio Sato, Toshio Inage, Motohiro Kobayashi